{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:12:55Z","timestamp":1771575175636,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670842"],"award-info":[{"award-number":["81670842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03205"],"award-info":[{"award-number":["2024C03205"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00417-025-06974-8","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:37:53Z","timestamp":1762763873000},"page":"579-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of 0.05% cyclosporine A on visual quality in patients with Post-refractive surgery dry eye"],"prefix":"10.1007","volume":"264","author":[{"given":"Xuze","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wumaier","family":"Ailixiati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4921-2399","authenticated-orcid":false,"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"4","key":"6974_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.4103\/ijo.Ijo_3406_22","volume":"71","author":"S Nair","year":"2023","unstructured":"Nair S, Kaur M, Sharma N, Titiyal JS (2023) Refractive surgery and dry eye - an update. Indian J Ophthalmol 71(4):1105\u20131114. https:\/\/doi.org\/10.4103\/ijo.Ijo_3406_22","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"6974_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK et al (2017) Tfos dews II definition and classification report. Ocul Surf 15(3):276\u2013283. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008","journal-title":"Ocul Surf"},{"issue":"1","key":"6974_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.aopr.2024.01.008","volume":"4","author":"Z Lv","year":"2024","unstructured":"Lv Z, Li S, Zeng G, Yao K, Han H (2024) Recent progress of nanomedicine in managing dry eye disease. Adv Ophthalmol Pract Res 4(1):23\u201331. https:\/\/doi.org\/10.1016\/j.aopr.2024.01.008","journal-title":"Adv Ophthalmol Pract Res"},{"issue":"12","key":"6974_CR4","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.4103\/ijo.IJO_2296_19","volume":"68","author":"B Sharma","year":"2020","unstructured":"Sharma B, Soni D, Saxena H, Stevenson LJ, Karkhur S, Takkar B et al (2020) Impact of corneal refractive surgery on the precorneal tear film. Indian J Ophthalmol 68(12):2804\u20132812. https:\/\/doi.org\/10.4103\/ijo.IJO_2296_19","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"6974_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S et al (2017) Tfos dews II pathophysiology report. Ocul Surf 15(3):438\u2013510. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.011","journal-title":"Ocul Surf"},{"issue":"9","key":"6974_CR6","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.ophtha.2012.03.004","volume":"119","author":"A Denoyer","year":"2012","unstructured":"Denoyer A, Rabut G, Baudouin C (2012) Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology 119(9):1811\u20131818. https:\/\/doi.org\/10.1016\/j.ophtha.2012.03.004","journal-title":"Ophthalmology"},{"key":"6974_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.actbio.2022.01.044","volume":"141","author":"PH Lin","year":"2022","unstructured":"Lin PH, Jian HJ, Li YJ, Huang YF, Anand A, Huang CC et al (2022) Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels. Acta Biomater 141:140\u2013150. https:\/\/doi.org\/10.1016\/j.actbio.2022.01.044","journal-title":"Acta Biomater"},{"issue":"24","key":"6974_CR8","doi-asserted-by":"publisher","first-page":"25118","DOI":"10.1021\/acsnano.3c07817","volume":"17","author":"CJ Yang","year":"2023","unstructured":"Yang CJ, Anand A, Huang CC, Lai JY (2023) Unveiling the power of Gabapentin-Loaded nanoceria with multiple therapeutic capabilities for the treatment of dry eye disease. ACS Nano 17(24):25118\u201325135. https:\/\/doi.org\/10.1021\/acsnano.3c07817","journal-title":"ACS Nano"},{"issue":"1","key":"6974_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12951-024-02448-x","volume":"22","author":"HL Bui","year":"2024","unstructured":"Bui HL, Su YH, Yang CJ, Huang CJ, Lai JY (2024) Mucoadhesive, antioxidant, and lubricant catechol-functionalized poly(phosphobetaine) as biomaterial nanotherapeutics for treating ocular dryness. J Nanobiotechnol 22(1):160. https:\/\/doi.org\/10.1186\/s12951-024-02448-x","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"6974_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcrs.2007.08.028","volume":"34","author":"BA Levinson","year":"2008","unstructured":"Levinson BA, Rapuano CJ, Cohen EJ, Hammersmith KM, Ayres BD, Laibson PR (2008) Referrals to the Wills Eye Institute cornea service after laser in situ keratomileusis: reasons for patient dissatisfaction. J Cataract Refract Surg 34(1):32\u201339. https:\/\/doi.org\/10.1016\/j.jcrs.2007.08.028","journal-title":"J Cataract Refract Surg"},{"issue":"14","key":"6974_CR11","doi-asserted-by":"publisher","first-page":"Des109","DOI":"10.1167\/iovs.17-23538","volume":"59","author":"I Toda","year":"2018","unstructured":"Toda I, Dry Eye After LASIK (2018) Invest Ophthalmol Vis Sci 59(14):Des109\u2013des15. https:\/\/doi.org\/10.1167\/iovs.17-23538","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6974_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4903831","volume":"2018","author":"E Cohen","year":"2018","unstructured":"Cohen E, Spierer O (2018) Dry eye post-laser-assisted in situ keratomileusis: major review and latest updates. J Ophthalmol 2018:4903831. https:\/\/doi.org\/10.1155\/2018\/4903831","journal-title":"J Ophthalmol"},{"issue":"3","key":"6974_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jcrs.2003.07.003","volume":"30","author":"JM Albietz","year":"2004","unstructured":"Albietz JM, Lenton LM, McLennan SG (2004) Chronic dry eye and regression after laser in situ keratomileusis for myopia. J Cataract Refract Surg 30(3):675\u2013684. https:\/\/doi.org\/10.1016\/j.jcrs.2003.07.003","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"6974_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/ceo.13315","volume":"46","author":"MK Yan","year":"2018","unstructured":"Yan MK, Chang JS, Chan TC (2018) Refractive regression after laser in situ keratomileusis. Clin Exp Ophthalmol 46(8):934\u2013944. https:\/\/doi.org\/10.1111\/ceo.13315","journal-title":"Clin Exp Ophthalmol"},{"key":"6974_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1342056","volume":"2016","author":"N Lu","year":"2016","unstructured":"Lu N, Lin F, Huang Z, He Q, Han W (2016) Changes of corneal wavefront aberrations in dry eye patients after treatment with artificial lubricant drops. J Ophthalmol 2016:1342056. https:\/\/doi.org\/10.1155\/2016\/1342056","journal-title":"J Ophthalmol"},{"issue":"2","key":"6974_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.aopr.2024.01.006","volume":"4","author":"L Lin","year":"2024","unstructured":"Lin L, Zhu Y, Yuan K, Mou Y, Zhao H, Wu Y et al (2024) Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye. Adv Ophthalmol Pract Res 4(2):47\u201351. https:\/\/doi.org\/10.1016\/j.aopr.2024.01.006","journal-title":"Adv Ophthalmol Pract Res"},{"issue":"4","key":"6974_CR17","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.21037\/apm-20-1453","volume":"10","author":"Y Wu","year":"2021","unstructured":"Wu Y, Jin X, Mou Y, Yuan K, Min J, Huang X (2021) A 4-week, randomized, double-masked study to evaluate efficacy of deproteinized calf blood extract eye drops versus sodium hyaluronate 0.3% eye drops in dry eye patients with ocular pain. Ann Palliat Med 10(4):3617\u20133625. https:\/\/doi.org\/10.21037\/apm-20-1453","journal-title":"Ann Palliat Med"},{"key":"6974_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1160499","volume":"10","author":"T Wang","year":"2023","unstructured":"Wang T, Di Y, Li Y (2023) Combination therapy with 3% Diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis. Front Med Lausanne 10:1160499. https:\/\/doi.org\/10.3389\/fmed.2023.1160499","journal-title":"Front Med Lausanne"},{"key":"6974_CR19","doi-asserted-by":"crossref","unstructured":"Xu G, An L, Yuan G, Li H, Du P (2016) Review on healing eye disease using deproteinized calf blood extraction","DOI":"10.2991\/mmeceb-15.2016.15"},{"issue":"3","key":"6974_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102353","volume":"48","author":"B Guo","year":"2025","unstructured":"Guo B, Chan KY, Li PH, Tse JSH, Liao X, Eng D et al (2025) Validation and repeatability assessment of the Chinese version of the ocular surface disease index (OSDI), 5-item dry eye (DEQ-5), and contact lens dry eye questionnaire-8 (CLDEQ-8) questionnaires. Contact Lens Anterior Eye 48(3):102353. https:\/\/doi.org\/10.1016\/j.clae.2024.102353","journal-title":"Contact Lens Anterior Eye"},{"key":"6974_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111095","volume":"115","author":"LJ Luo","year":"2020","unstructured":"Luo LJ, Nguyen DD, Lai JY (2020) Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease. Mater Sci Eng C Mater Biol Appl 115:111095. https:\/\/doi.org\/10.1016\/j.msec.2020.111095","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"2","key":"6974_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/sstr.202400484","volume":"6","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Su YH, Yang CJ, Lai JY (2024) Design of highly adhesive urchin-like gold nanostructures for effective topical drug administration and symptomatic relief of corneal dryness. Small Struct 6(2):2400484. https:\/\/doi.org\/10.1002\/sstr.202400484","journal-title":"Small Struct"},{"key":"6974_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2021.100183","volume":"13","author":"DD Nguyen","year":"2022","unstructured":"Nguyen DD, Luo LJ, Lai JY (2022) Thermogels containing sulfated hyaluronan as novel topical therapeutics for treatment of ocular surface inflammation. Mater Today Bio 13:100183. https:\/\/doi.org\/10.1016\/j.mtbio.2021.100183","journal-title":"Mater Today Bio"},{"issue":"3","key":"6974_CR24","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1177\/11206721221141481","volume":"33","author":"EM Messmer","year":"2023","unstructured":"Messmer EM, Ahmad S, Del Benitez JM, Mrukwa-Kominek E, Rolando M, Vitovska O et al (2023) Management of inflammation in dry eye disease: recommendations from a European panel of experts. Eur J Ophthalmol 33(3):1294\u20131307. https:\/\/doi.org\/10.1177\/11206721221141481","journal-title":"Eur J Ophthalmol"},{"key":"6974_CR25","doi-asserted-by":"publisher","unstructured":"Liu SH, Saldanha IJ, Abraham AG, Rittiphairoj T, Hauswirth S, Gregory D et al Topical corticosteroids for dry eye. Cochrane Database Syst Reviews. 2022(10). https:\/\/doi.org\/10.1002\/14651858.CD015070.pub2","DOI":"10.1002\/14651858.CD015070.pub2"},{"issue":"8","key":"6974_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1631\/jzus.2006.B0675","volume":"7","author":"CQ Yang","year":"2006","unstructured":"Yang CQ, Sun W, Gu YS (2006) A clinical study of the efficacy of topical corticosteroids on dry eye. J Zhejiang Univ Sci B 7(8):675\u2013678. https:\/\/doi.org\/10.1631\/jzus.2006.B0675","journal-title":"J Zhejiang Univ Sci B"},{"issue":"2","key":"6974_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/09273948.2017.1341988","volume":"27","author":"CA Cutolo","year":"2019","unstructured":"Cutolo CA, Barabino S, Bonzano C, Traverso CE (2019) The use of topical corticosteroids for treatment of dry eye syndrome. Ocul Immunol Inflamm 27(2):266\u2013275. https:\/\/doi.org\/10.1080\/09273948.2017.1341988","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"6974_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1055\/a-1115-4756","volume":"237","author":"U Pleyer","year":"2020","unstructured":"Pleyer U, Geerling G, Schrader S, Jacobi C, Kimmich F, Messmer E (2020) Wenn Tr\u00e4nenersatzmittel nicht mehr ausreichen: die Bedeutung von Entz\u00fcndungsprozessen beim Trockenen Auge. Praktische Aspekte einer antientz\u00fcndlichen Therapie des Trockenen Auges. Klin Monbl Augenheilkd 237(5):655\u2013668. https:\/\/doi.org\/10.1055\/a-1115-4756","journal-title":"Klin Monbl Augenheilkd"},{"issue":"8","key":"6974_CR29","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/09273948.2022.2088566","volume":"31","author":"M Labetoulle","year":"2023","unstructured":"Labetoulle M, Leonardi A, Pisella PJ, Baudouin C (2023) Ciclosporin A cationic emulsion 0.1% for the management of dry eye disease: facts that matter for eye-care providers. Ocul Immunol Inflamm 31(8):1707\u20131715. https:\/\/doi.org\/10.1080\/09273948.2022.2088566","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"6974_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/09273948.2016.1276933","volume":"25","author":"A Leonardi","year":"2017","unstructured":"Leonardi A, Flamion B, Baudouin C (2017) Keratitis in dry eye disease and topical ciclosporin A. Ocul Immunol Inflamm 25(4):577\u2013586. https:\/\/doi.org\/10.1080\/09273948.2016.1276933","journal-title":"Ocul Immunol Inflamm"},{"issue":"11s","key":"6974_CR31","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","volume":"124","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder SC, de Paiva CS (2017) The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology 124(11s):S4\u2013s13. https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.010","journal-title":"Ophthalmology"},{"issue":"3","key":"6974_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","volume":"54","author":"E Donnenfeld","year":"2009","unstructured":"Donnenfeld E, Pflugfelder SC (2009) Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol 54(3):321\u2013338. https:\/\/doi.org\/10.1016\/j.survophthal.2009.02.002","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"6974_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/s0161-6420(00)00035-x","volume":"107","author":"D Stevenson","year":"2000","unstructured":"Stevenson D, Tauber J, Reis BL (2000) Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The cyclosporin A phase 2 study group. Ophthalmology 107(5):967\u2013974. https:\/\/doi.org\/10.1016\/s0161-6420(00)00035-x","journal-title":"Ophthalmology"},{"issue":"9","key":"6974_CR34","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/ICO.0b013e31820cd607","volume":"30","author":"BH Jeng","year":"2011","unstructured":"Jeng BH, Holsclaw DS (2011) Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis. Cornea 30(9):958\u2013961. https:\/\/doi.org\/10.1097\/ICO.0b013e31820cd607","journal-title":"Cornea"},{"issue":"10","key":"6974_CR35","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","volume":"112","author":"LD Barber","year":"2005","unstructured":"Barber LD, Pflugfelder SC, Tauber J, Foulks GN (2005) Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology 112(10):1790\u20131794. https:\/\/doi.org\/10.1016\/j.ophtha.2005.05.013","journal-title":"Ophthalmology"},{"issue":"4","key":"6974_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3928\/01913913-20220420-03","volume":"59","author":"DG Ghiglioni","year":"2022","unstructured":"Ghiglioni DG, Bruschi G, Centonze S, Calcinai E, Cozzi L, Osnaghi S et al (2022) Cyclosporine A 0.1% cationic emulsion in vernal keratoconjunctivitis. J Pediatr Ophthalmol Strabismus 59(4):279. https:\/\/doi.org\/10.3928\/01913913-20220420-03","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"4","key":"6974_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/jop.2009.0145","volume":"26","author":"M Chen","year":"2010","unstructured":"Chen M, Gong L, Sun X, Xie H, Zhang Y, Zou L et al (2010) A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial. J Ocul Pharmacol Ther 26(4):361\u2013366. https:\/\/doi.org\/10.1089\/jop.2009.0145","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"6974_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan KH, Chen LJ, Young AL (2015) Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13(3):213\u2013225. https:\/\/doi.org\/10.1016\/j.jtos.2014.12.006","journal-title":"Ocul Surf"},{"key":"6974_CR39","doi-asserted-by":"publisher","unstructured":"Kim EC, Choi JS, Joo CK (2009) A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. Am J Ophthalmol. ;147(2):206\u2009\u2013\u200913 e3. https:\/\/doi.org\/10.1016\/j.ajo.2008.08.015","DOI":"10.1016\/j.ajo.2008.08.015"},{"issue":"3","key":"6974_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4103\/djo.djo_7_21","volume":"22","author":"IY ElShazly","year":"2021","unstructured":"ElShazly IY, Morsy MH, Bekhit AA, Ramadan AA, Mossallam EF (2021) Topical cyclosporine A for the treatment of dry eye: a randomized clinical study. Delta J Ophthalmol 22(3):165\u2013174. https:\/\/doi.org\/10.4103\/djo.djo_7_21","journal-title":"Delta J Ophthalmol"},{"issue":"5","key":"6974_CR41","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41433-023-02807-2","volume":"38","author":"X Jiao","year":"2024","unstructured":"Jiao X, Qi Y, Gao N, Zhang C, Zhao S, Yang R (2024) Exploration of efficacy and mechanism of 0.05% cyclosporine eye drops (II) monotherapy in allergic conjunctivitis-associated dry eye. Eye 38(5):937\u2013944. https:\/\/doi.org\/10.1038\/s41433-023-02807-2","journal-title":"Eye"},{"issue":"4","key":"6974_CR42","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.3928\/1081597x-20240311-03","volume":"40","author":"X Zhu","year":"2024","unstructured":"Zhu X, Li S, Wang M, Yao W, Huang X, Zhao L (2024) Effects of topical 0.05% cyclosporine A on dry eye symptoms and parameters following small incision lenticule extraction. J Refract Surg 40(4):e229\u2013e38. https:\/\/doi.org\/10.3928\/1081597x-20240311-03","journal-title":"J Refract Surg"},{"issue":"1","key":"6974_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12886-024-03294-z","volume":"24","author":"L Zhao","year":"2024","unstructured":"Zhao L, Chen J, Duan H, Yang T, Ma B, Zhou Y et al (2024) Efficacy of topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in post-refractive surgery chronic dry eye patients with ocular pain. BMC Ophthalmol 24(1):28. https:\/\/doi.org\/10.1186\/s12886-024-03294-z","journal-title":"BMC Ophthalmol"},{"key":"6974_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/icl.0000000000001103","author":"L Zhao","year":"2024","unstructured":"Zhao L, Duan H, Ma B, Yang T, Zhou Y, Liu Y et al (2024) Impact of topical 0.05% cyclosporine A eye drops on post-Femtosecond-assisted laser in situ keratomileusis ocular surface recovery: a randomized clinical trial. Eye Contact Lens. https:\/\/doi.org\/10.1097\/icl.0000000000001103","journal-title":"Eye Contact Lens"},{"key":"6974_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jtos.2025.01.010","volume":"36","author":"JS Wolffsohn","year":"2025","unstructured":"Wolffsohn JS, Trave-Huarte S, Stapleton F, Downie LE, Schulze MM, Guthrie S, Stahl Ulrike, Wang Michael T.M., Craig Jennifer P. (2025) Relative importance of tear homeostatic signs for the diagnosis of dry eye disease. Ocul Surf 36:151\u2013155. https:\/\/doi.org\/10.1016\/j.jtos.2025.01.010","journal-title":"Ocul Surf"},{"issue":"12","key":"6974_CR46","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1167\/iovs.12-10610","volume":"53","author":"A Hartwig","year":"2012","unstructured":"Hartwig A, Atchison DA (2012) Analysis of higher-order aberrations in a large clinical population. Invest Ophthalmol Vis Sci 53(12):7862\u20137870. https:\/\/doi.org\/10.1167\/iovs.12-10610","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"6974_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.61.10.39","volume":"61","author":"SE Singh","year":"2020","unstructured":"Singh SE, Wildsoet CF, Roorda AJ (2020) Optical aberrations of Guinea pig eyes. Invest Ophthalmol Vis Sci 61(10):39. https:\/\/doi.org\/10.1167\/iovs.61.10.39","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"6974_CR48","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3928\/1081597X-20170310-01","volume":"33","author":"H Kandel","year":"2017","unstructured":"Kandel H, Khadka J, Lundstrom M, Goggin M, Pesudovs K (2017) Questionnaires for measuring refractive surgery outcomes. J Refract Surg 33(6):416\u2013424. https:\/\/doi.org\/10.3928\/1081597X-20170310-01","journal-title":"J Refract Surg"},{"issue":"11","key":"6974_CR49","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1167\/iovs.10-5341","volume":"51","author":"C McAlinden","year":"2010","unstructured":"McAlinden C, Pesudovs K, Moore JE (2010) The development of an instrument to measure quality of vision: the quality of vision (QoV) questionnaire. Invest Ophthalmol Vis Sci 51(11):5537\u20135545. https:\/\/doi.org\/10.1167\/iovs.10-5341","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6974_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10080559","author":"Y Okumura","year":"2020","unstructured":"Okumura Y, Inomata T, Iwata N, Sung J, Fujimoto K, Fujio K et al (2020) A review of dry eye questionnaires: measuring patient-reported outcomes and health-related quality of life. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics10080559","journal-title":"Diagnostics"},{"issue":"2","key":"6974_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/opx.0000000000001638","volume":"98","author":"M-M Schulze","year":"2021","unstructured":"Schulze M-M, Ng A, Yang M, Panjwani F, Srinivasan S, Jones LW et al (2021) Bulbar redness and dry eye disease: comparison of a validated subjective grading scale and an objective automated method. Optom Vis Sci 98(2):113\u2013120. https:\/\/doi.org\/10.1097\/opx.0000000000001638","journal-title":"Optom Vis Sci"},{"issue":"4","key":"6974_CR52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3785\/j.issn.1008-9292.2016.07.14","volume":"45","author":"K Zhu","year":"2016","unstructured":"Zhu K, Xie W, Ying J, Yao Y (2016) [Evaluation of tear film and meibomian gland function in dry eye patients using keratograph 5\u00a0M]. Zhejiang Da Xue Xue Bao Yi Xue Ban 45(4):422\u2013428. https:\/\/doi.org\/10.3785\/j.issn.1008-9292.2016.07.14","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"6974_CR53","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","volume":"52","author":"JD Nelson","year":"2011","unstructured":"Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S et al (2011) The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52(4):1930\u20137. https:\/\/doi.org\/10.1167\/iovs.10-6997b","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6974_CR54","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/opth.S398843","volume":"17","author":"K Sall","year":"2023","unstructured":"Sall K, Foulks GN, Pucker AD, Ice KL, Zink RC, Magrath G (2023) Validation of a modified National Eye Institute grading scale for corneal fluorescein staining. Clin Ophthalmol 17:757\u2013767. https:\/\/doi.org\/10.2147\/opth.S398843","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"6974_CR55","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/s0886-3350(03)00467-x","volume":"29","author":"L Wang","year":"2003","unstructured":"Wang L, Dai E, Koch DD, Nathoo A (2003) Optical aberrations of the human anterior cornea. J Cataract Refract Surg 29(8):1514\u20131521. https:\/\/doi.org\/10.1016\/s0886-3350(03)00467-x","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"6974_CR56","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1167\/iovs.10-7102","volume":"52","author":"J Xu","year":"2011","unstructured":"Xu J, Bao J, Deng J, Lu F, He JC (2011) Dynamic changes in ocular Zernike aberrations and tear menisci measured with a wavefront sensor and an anterior segment OCT. Invest Ophthalmol Vis Sci 52(8):6050\u20136056. https:\/\/doi.org\/10.1167\/iovs.10-7102","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"18","key":"6974_CR57","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000010618","volume":"97","author":"J Wang","year":"2018","unstructured":"Wang J, Ren Y, Liang K, Jiang Z, Tao L (2018) Changes of corneal high-order aberrations after femtosecond laser-assisted in situ keratomileusis. Medicine (Baltimore) 97(18):e0618. https:\/\/doi.org\/10.1097\/md.0000000000010618","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"6974_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3928\/1081-597x-20040501-08","volume":"20","author":"R Mont\u00e9s-Mic\u00f3","year":"2004","unstructured":"Mont\u00e9s-Mic\u00f3 R, C\u00e1liz A, Ali\u00f3 JL (2004) Wavefront analysis of higher order aberrations in dry eye patients. J Refract Surg 20(3):243\u2013247. https:\/\/doi.org\/10.3928\/1081-597x-20040501-08","journal-title":"J Refract Surg"},{"issue":"1","key":"6974_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/cxo.13111","volume":"104","author":"Y Gao","year":"2021","unstructured":"Gao Y, Liu R, Liu Y, Ma B, Yang T, Hu C et al (2021) Optical quality in patients with dry eye before and after treatment. Clin Exp Optom 104(1):101\u2013106. https:\/\/doi.org\/10.1111\/cxo.13111","journal-title":"Clin Exp Optom"},{"issue":"5","key":"6974_CR60","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1046\/j.1475-1313.2002.00072.x","volume":"22","author":"HC Howland","year":"2002","unstructured":"Howland HC (2002) High order wave aberration of eyes. Ophthalmic Physiol Opt 22(5):434\u2013439. https:\/\/doi.org\/10.1046\/j.1475-1313.2002.00072.x","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06974-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06974-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06974-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:42:58Z","timestamp":1771573378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06974-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6974"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06974-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of The Second Affiliated Hospital of Zhejiang University School of Medicine (Approval No. 2024\u2009\u2212\u20091127).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Informed consent was obtained from all individual participants includedInformed consent was obtained from all individual participants included\u00a0in the study. Patients also signed informed consent regarding publishing\u00a0their data and photographs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/Consent to publish"}},{"value":"The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}